{
    "clinical_study": {
        "@rank": "52064", 
        "arm_group": [
            {
                "arm_group_label": "Fresh blood transfusion", 
                "arm_group_type": "Active Comparator", 
                "description": "One unit of blood stored for less than 14 days"
            }, 
            {
                "arm_group_label": "Standard issue blood transfusion", 
                "arm_group_type": "Experimental", 
                "description": "One unit of blood stored under standard conditions"
            }
        ], 
        "brief_summary": {
            "textblock": "Transfusion of stored blood has been associated with increased pulmonary vascular resistance\n      in lambs. The investigators hypothesize that transfusion of one unit of red blood cells\n      stored under standard conditions in intensive care patients will increase pulmonary arterial\n      pressure and pulmonary vascular resistance to a greater extent than will one unit of fresh\n      red blood cells."
        }, 
        "brief_title": "Hemodynamic Effects of Stored Blood Transfusion in Intensive Care Patients", 
        "condition": "Pulmonary Hypertension", 
        "condition_browse": {
            "mesh_term": [
                "Hypertension", 
                "Hypertension, Pulmonary"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. The patient has a pulmonary artery catheter in place\n\n          2. Transfusion of 1 unit of packed red blood cells indicated for standard intensive care\n             therapy\n\n          3. The patient has an arterial catheter\n\n        Exclusion Criteria:\n\n          1. Age < 18 years\n\n          2. Clinical prediction that the patient will not survive at least 48 hours\n\n          3. Acute bleeding: > 2 units of packed red blood cells/hour\n\n          4. Vasopressor use: noradrenalin > 0.2 \u03bcg/kg/min or any use of adrenalin within 6 hours\n             of inclusion into the study\n\n          5. Therapy with inhaled NO, inhaled prostacyclin, or phosphodiesterase-5-inhibitors\n\n          6. Sepsis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "64", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 17, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02050230", 
            "org_study_id": "BASG 2013-002316-27", 
            "secondary_id": "2013-002316-27"
        }, 
        "intervention": {
            "arm_group_label": [
                "Fresh blood transfusion", 
                "Standard issue blood transfusion"
            ], 
            "description": "One unit of red blood cells will be transfused over the course of 20 minutes", 
            "intervention_name": "Blood transfusion", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "transfusion", 
            "pulmonary hypertension", 
            "intensive care medicine"
        ], 
        "lastchanged_date": "January 30, 2014", 
        "location": {
            "contact": {
                "last_name": "David M Baron, MD"
            }, 
            "facility": {
                "address": {
                    "city": "Vienna", 
                    "country": "Austria", 
                    "zip": "1090"
                }, 
                "name": "General Hospital of the Medical University of Vienna"
            }, 
            "investigator": [
                {
                    "last_name": "David M Baron, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Roman Ullich, MD", 
                    "role": "Principal Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Austria"
        }, 
        "number_of_arms": "2", 
        "official_title": "Hemodynamic Effects of Stored Blood Transfusion in Intensive Care Patients", 
        "overall_contact": {
            "email": "david.baron@meduniwien.ac.at", 
            "last_name": "David M Baron, MD", 
            "phone": "0043140400", 
            "phone_ext": "4100"
        }, 
        "overall_official": {
            "affiliation": "Medical University of Vienna", 
            "last_name": "Roman Ullrich, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Austria: Ethikkommission", 
                "Austria: Agency for Health and Food Safety"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Pulmonary arterial pressure", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to immediately after transfusion (time frame of 20 min)"
            }, 
            {
                "measure": "Pulmonary vascular resistance", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to immediately after transfusion (time frame of 20 min)"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02050230"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Medical University of Vienna", 
            "investigator_full_name": "David M Baron, MD", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Systemic pressure", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to immediately after transfusion (time frame of 20 min)"
            }, 
            {
                "measure": "Systemic vascular resistance", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to immediately after transfusion (time frame of 20 min)"
            }
        ], 
        "source": "Medical University of Vienna", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medical University of Vienna", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}